Extramural Funding

SEPA supports educational activities for pre-kindergarten to grade 12 (P-12) to ensure that students and teachers from all communities and regions of the country have the opportunity to pursue studies in science, technology , engineering, and mathematics (STEM).

NIH is the largest public founder of biomedical research in the world. Weekly updates allow researchers to track newly published funding opportunities and notices.

The American Heart Association, the largest non-profit, non-governmental funder of cardiovascular and cerebrovascular research in the U.S., offers both annually and one-time grants. Some programs require pre-proposals, with full proposals by invitation only. 

OREF Clinical Research Award recognizes outstanding clinical research related directly to musculoskeletal disease or injury.

Submission Deadline: July 1, 2024

The Congressionally Directed Medical Research Programs (CDMRP) fosters novel approaches to biomedical research in response to the expressed needs of its stakeholders—the American public, the military, and Congress. Research programs include topics such as breast cancer, ovarian cancer, rare cancer, kidney cancer, and reconstructive transplants.

NPIN is an information and resource platform connecting public health partners through collaborative communication and innovative technology solutions for HIV, viral hepatitis, STDs, TB, and adolescent and school health. 

The  Development and Advancement of Radiopharmaceutical Therapies Convergent Research Initiative Pilot Collaborative Grant initiates and establishes collaborations within the radiotherapeutics-related research community. This enables future successful collaborative funding applications and jumpstarts work with newly recruited convergent research initiative investigators. 

Submission Deadline: July 5, 2024

SFARI: Linking Early Neurodevelopment to Neural Circuit Outcomes invites proposals that will elucidate the impact of well-defined developmental alterations on the structure, function and/or output of neural circuits relevant to ASD phenotypes.      

Submission Deadline: September 12, 2024, 11:00am Central

This program encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies, and prevention. Apply under Level 1: basic physician scientists who have received their degrees no more than 18 months prior to the application; or Level 2: Physician-scientists who have completed their residencies and clinical training and are board-eligible and able to devote 80% of their time to Damon Runyon-supported research activities. No limit on the number of applications from an institution; only one application will be accepted from a Sponsor/Fellow per review session. 

Application Deadline: August 15, 2024, 4:00pm Central

The major goal of this initiative is to identify and support promising junior investigators committed to aging research and geroscience with at least 3 years of independent research. Proposed projects should focus on understanding the basic mechanisms of aging rather than disease-specific research.

Letter of Intent Deadline: July 15, 2024

This international pilot initiative seeks to increase, retain, and diversify the number of PhD or MD/PhD postdoctoral trainees in healthy aging research, to foster scientific exchange between the US, Canada, UK, and Europe, and to further their mission of “Extending healthy lifespan for the benefit of all humanity”.

Letter of Intent Deadline: July 15, 2024

The major goal of this program is to identify emerging scientific leaders by building a cadre of outstanding research scientists to lead transformative research in this field. One award will support studies focusing on clinical translational research while a second award will support studies of basic biological mechanisms.

Application Deadline: August 12, 2024

Through a collaboration between NIA, the American Federation for Aging Research, and the John A. Hartford Foundation, this initiative hopes to recruit talented new investigators who have begun to establish research programs, and who are ready to assume leadership roles in their field of expertise. Candidates must have competitively awarded research support as PD/PI at the faculty level and have prior leadership responsibilities in the clinical or research domain. Both opportunities support early-stage clinician-investigators. RFA-AG-24-014 is for those not leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. RFA-AG-24-015 is for those proposing a clinical trial or an ancillary clinical trial as lead investigator.

Application Deadline: October 18, 2024

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) encourages and retains outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. This award facilitates the transition of talented graduate students into successful cancer research postdoctoral appointments and provides opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. UT Health Science Center may submit one application.

UT Health Science Center Limited Submission Deadline: July 31, 2024

WEBINAR RECORDING

NIH Grants Process: A Brief Walk-Through for Beginners

BOOTCAMP: July 25 - September 10, 2024

NIH Entrepreneurship Boot Camp for pre-SBIR/STTR Innovators